Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients
Authors:
- Jung Mogg KimJKJung Mogg Kim
- Joo Sung KimJKJoo Sung Kim
- Nayoung KimNKNayoung Kim
- Hyun Chae JungHJHyun Chae Jung
- In Sung SongISIn Sung Song
Open Access
- 13 September 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 56 (5) , 965-967
Abstract
Objectives: The aim of this study was to assess the prevalence rate of primary fluoroquinolone resistance in Helicobacter pylori isolates from Korean patients over the past 16 years. Methods: One hundred and thirty-five strains of H. pylori (34 strains in 1987, 36 in 1994 and 65 in 2003) were isolated from antral gastric mucosal biopsy specimens. The determination of MICs for the H. pylori isolates of ciprofloxacin, levofloxacin and moxifloxacin was examined by using the serial 2-fold agar dilution method. DNA sequences of the gyrA gene in fluoroquinolone-resistant strains were determined. Results: The distribution of fluoroquinolone MICs (ciprofloxacin, levofloxacin and moxifloxacin) shifted to higher concentrations during 1987–2003. All of the levofloxacin- or moxifloxacin-resistant strains were resistant to ciprofloxacin. Sequence analysis in fluoroquinolone-resistant strains showed point mutation of the gyrA gene at A272G and G271A, indicating mutations of the codon Asp-91 in the fluoroquinolone-resistance-determining region of the DNA gyrase. Conclusions: These results suggest that resistance to fluoroquinolones has been increasing in the Korean population and the resistance is most likely mediated through point mutation in gyrA.Keywords
This publication has 8 references indexed in Scilit:
- Distribution of Antibiotic MICs for Helicobacter pylori Strains over a 16-Year Period in Patients from Seoul, South KoreaAntimicrobial Agents and Chemotherapy, 2004
- In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from childrenJournal of Medical Microbiology, 2004
- Singleand Double Mutations in gyrA but Not in gyrB AreAssociated with Low- and High-Level Fluoroquinolone Resistance in HelicobacterpyloriAntimicrobial Agents and Chemotherapy, 2003
- Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999)Journal of Antimicrobial Chemotherapy, 2000
- Efficacy of two one‐week rabeprazole/levofloxacin‐based triple therapies for Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 2000
- Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy.European Journal of Clinical Microbiology & Infectious Diseases, 2000
- Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The NetherlandsJournal of Antimicrobial Chemotherapy, 1999
- Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pyloriAntimicrobial Agents and Chemotherapy, 1995